UNIVERSITY OF TOLEDO

Similar documents
BIOMEDICAL WASTE MANAGEMENT POLICY

University Health Services Health and Safety

Appendix J. University of Alabama at Birmingham Medical Waste Management Plan

Policy & Procedure Manual

UNIVERSITY OF RICHMOND REGULATED MEDICAL WASTE MANAGEMENT GUIDELINES

Infectious Waste Disposal Procedure 25 PA Code 284 Ursinus College Collegeville, PA 19426

Biological and Regulated Medical Waste Plan

Northeastern University Procedure for Disposal of Medical or Biological Waste

WHO NEEDS TO KNOW THIS PROGRAM All NYU employees that generate, handle or transport RMW should be familiar with this written program.

Regulated Medical Waste Management and Proper Waste Segregation. State-Specific Information Washington

INFECTIOUS/BIOLOGICAL WASTE MANAGEMENT PROTOCOL

SOP BIO-006 USE OF AUTOCLAVE FOR STERILIZATION OF MATERIALS AND BIOLOGICAL WASTE

University Health Services Health and Safety REGULATIONS FOR AUTOCLAVE USE, MAINTENANCE AND RECORDKEEPING

Regulated Medical Waste (RMW) Rules, Registration & Reports

DEPARTMENT OF BIOLOGICAL SCIENCES MEDICAL/BIOHAZARDOUS WASTE DISPOSAL AUTOCLAVE TRAINING

Biological Safety Program. For. Otterbein University

CALIFORNIA CODES HEALTH AND SAFETY CODE SECTION

Biomedical Waste Management Plan

nc.us/swhome/

Employee Environmental, Health & Safety Manual. INFECTIOUS WASTE MANAGEMENT PROGRAM Latest Revision: 05/27/08

ENVIRONMENTAL MANAGEMENT GUIDE FOR SMALL LABORATORIES

Contents. Introduction

PROGRAM FOR THE MANAGEMENT AND DISPOSAL OF RADIOACTIVE WASTE

Biomedical Waste Management Guide

BIO-MEDICAL WASTE MANAGEMENT (AMENDMENT) RULES -2018

LABORATORY WASTE MANAGEMENT PROGRAMMES

DOT Hazardous Materials and Regulated Medical Waste Prepared By: George Weishoff

Environmental Management Chapter ALABAMA DEPARTMENT OF ENVIRONMENTAL MANAGEMENT LAND DIVISION MEDICAL WASTE PROGRAM ADMINISTRATIVE CODE

Biosafety Level 1 ( BSL1 ) and Biosafety Level 2 ( BSL2 ) Biological Waste Management Guideline

SESSION 4 AND HOSPITAL-GENERATED WASTE WASTE DISPOSAL AT THE MEDICAL CENTER OF THE UNIVERSITY OF ILLINOIS. Stephens. Raymond S.

Medical, Pathological and Low-level Radioactive Waste Management Plan for Incinerator Revised 3-08

Biosafety Checklist. 07-BiosafetyChecklist-LTC-SOP-v2.0-17Feb of 6

Dartmouth College. Institutional Biosafety Committee. Biohazardous Waste Disposal Guide IBC Approved: 10/3/18

Dartmouth College. Institutional Biosafety Committee. Biohazardous Waste Disposal Guide IBC Approved: 4/5/17

Health Sciences Campus Biomedical Waste Management Standard Operating Procedure (SOP)

UNIVERSITY OF TOLEDO

PI s Name Date Bldg./Rm#

WASTE MANAGEMENT GUIDE. Creighton University Environmental Health and Safety

FACT SHEET : Using Autoclaves Safely

Legal Aspects and Process of Biomedical Waste Management Practices in India. *Prakash V **Dr. N. Palaniraj

Biological Materials and Biohazardous/Medical Waste Disposal Program

MEDICAL WASTE MANAGEMENT ACT ATTENTION ALL GENERATORS OF MEDICAL WASTE

SECTION.1200 MEDICAL WASTE MANAGEMENT 15A NCAC 13B.1201 DEFINITIONS

Laboratory Close-Out Guidelines

BGSU s Biosafety and Infectious Waste Safety Procedures. Environmental Health & Safety 1851 N. Research Drive Bowling Green, OH

VIII. Biosafety Laboratory Practices and Equipment

Regulated Medical Waste Management and Proper Waste Segregation

Environmental Management System

You are required to complete this course with a passing score of 85% or higher if you:

المملكة العربية السعودية وزارة الصحة اإلدارة العامة لمكافحة عدوى المنشئات الصحية

Central Bio-Medical Waste Treatment Facility

2/07. PROCEDURE for DISPOSAL of RADIOACTIVE MATERIALS

UNIVERSITY OF TOLEDO

Radiation Safety Manual

Biosafety Program. I. Policy. Authority. Definitions

AREAS OF RESPONSIBILITY

RADIOACTIVE WASTE MANAGEMENT PLAN

Environment, Health and Safety

GUIDELINES FOR TRANSPORTING ANTHRAX AND ANTHRAX-CONTAMINATED OBJECTS AND MATERIALS

BIO-MEDICAL WASTE MANAGEMENT- CHALLENGES IN INDIA

MEDICAL WASTE MANAGEMENT STUDY NOTES

THE SAFE DISPOSAL OF CLINICAL/DOMESTIC WASTE

LABORATORY WASTE DISPOSAL GUIDE

Policy Name: Effective Date: 10/1/2013 Department/ Area Policy #:

WVU IACUC SOP: Radioactive Materials Used in Animal Studies

CHAPTER 31 BIOMEDICAL WASTE. by George F. Indest III, JD, MPA, LL.M SCOPE

Biological and Regulated Medical Waste Disposal Policy

Radioactive Waste Radiation Safety Orientation Open Source Booklet 7 (June 1, 2018)

UNIVERSITY OF TOLEDO HEALTH SCIENCE CAMPUS

Biomedical Waste Handling and Disposal

EVALUATION OF INFECTIOUS WASTE TREATMENT TECHNOLOGY INFORMATION REQUEST FORM

UNIVERSITY OF TOLEDO HEALTH SCIENCE CAMPUS

By: Georgia Institute of Technology

Environmental Management Chapter ALABAMA DEPARTMENT OF ENVIRONMENTAL MANAGEMENT LAND DIVISION MEDICAL WASTE PROGRAM ADMINISTRATIVE CODE

MEDICAL WASTE MANAGEMENT PLAN

PROGRAM FOR THE MANAGEMENT AND DISPOSAL OF BIOHAZARDOUS WASTE

Standard Operating Procedure Title: Good laboratory practices (GLP) for microbiology and chemistry laboratories

RMW Segregation Training H2E Fall Extravaganza October 2, 2009

Laboratory Waste Disposal

BIOMEDICAL WASTE FACILITY INSPECTION REPORT* Facility name: Permit #: Date of Inspection:

Section: Administration Date of Issue: 05/09/2011 Issued By: Administration Part: Pneumatic Tube System Revision #: Revision Date:

Lab Biosafety Self-Audit Form (Applies to all microbial work.)

Biosafety Protocol. Biodesign Swette Center for Environmental Biotechnology Standard Operating Procedures

York College. Regulated Wastes Awareness Training

Sterilization Policy. Georgia Regents Medical Center Policy Library. Policy Owner: Epidemiology POLICY STATEMENT

CLEMSON UNIVERSITY LAB CLOSE-OUT POLICY/PROCEDURES FOR HAZARDOUS SUBSTANCES, EQUIPMENT, SUPPLIES, ETC.

Pharmaceutical product means a restricted drug under the Health (Drugs and Poisons) Regulation 1996.

TITLE 17 REFUSE AND TRASH DISPOSAL 1 CHAPTER 1 REFUSE

10.0 DISPOSAL OF FARM WASTE

Animal cell and tissue culture. Lab 1

Management of Hazardous Wastes

Regulated Medical Waste Management and Proper Waste Segregation. Regulated Medical Waste Management and Proper Waste Segregation.

Laboratory Relocation Guidelines. Overview 2. Laboratory Close Out Contacts..3. Initial Laboratory Close Out Checklist...3

(No. 180) (Approved August 6, 2008) AN ACT

SECTION 11: SPECIAL WASTES MANAGEMENT

OREGON HEALTH & SCIENCE UNIVERSITY RADIATION SAFETY OPERATING PROCEDURE 1801 RADIOACTIVE WASTE HANDLING & STORAGE

3R approach towards bio-medical waste management

Lisa Young David Jansen. Public Health Always Working for a Safer and Healthier Washington

Standard Operating Procedure Safe Autoclave Operations

Guidelines for Laboratory Closure

Transcription:

UNIVERSITY OF TOLEDO SUBJECT: INFECTIOUS WASTE DISPOSAL Procedure No: HM-08-019 PROCEDURE STATEMENT Departments or laboratories generating infectious waste shall develop procedures for identification, segregation, handling and disposal of these wastes in compliance with Ohio Administrative Code (OAC) Chapters 3745-27 and 3745-37. Copies of the standard may be obtained from the Environmental Health and Radiation Safety Department. PURPOSE OF PROCEDURE To ensure safe handling and disposal of infectious wastes and to ensure compliance with applicable CDC, OSHA, EPA and Ohio Department of Health regulations and guidelines. PROCEDURE For the purpose of this policy, "infectious agent" means a type of microorganism, helminth, or virus that causes or significantly contributes to the cause of increased morbidity or mortality of human beings. For our purposes, infectious wastes include the following categories of waste. Questions regarding the designation of wastes as infectious may be directed to the the Environmental Health and Radiation Safety Department. A. Infectious Wastes Include: 1. Cultures and stocks of infectious agents and associated biologicals, including, without limitation, specimen cultures, cultures and stocks of infectious agents, wastes from production of biologicals, and discarded live and attenuated vaccines; 2. Laboratory wastes that were, or are likely to have been, in contact with infectious agents that may present a substantial threat to public health if improperly managed; 3. Pathological wastes, including, without limitation, human and animal tissues, organs, and body parts, and body fluids and excreta that are contaminated with or are likely to be contaminated with infectious agents, removed or obtained during surgery or autopsy or for diagnostic evaluation, provided that, with regard to pathological wastes from animals, the animals have or are likely to have been exposed to a zoonotic or infectious agent; 4. Waste materials from the rooms of humans, or the enclosures of animals, that have been isolated because of diagnosed communicable disease that are likely to transmit infectious agents. Also included are waste materials from the rooms of patients who have been placed on blood and body fluid precautions under the standard precaution system established by the Centers for Disease Control of the United States Department of Health and Human Services, if specific wastes generated under the standard precautions system have been identified as infectious wastes by rules referred to in paragraphs 1-8 of this section; 5. Human and animal blood specimens and blood products that are being disposed of, provided that, with regard to blood specimens and blood products from animals, the animals were or are likely to have been exposed to a zoonotic or infectious agent.. "Blood products" does not include patient care waste such as bandages or disposable gowns that are lightly soiled with blood or other body fluids, unless such wastes are soiled to the extent that the generator of the wastes determines that they should be managed as infectious wastes. Contaminated carcasses, body parts, and bedding of animals (see Segregation and Packaging) that were intentionally exposed to infectious from zoonotic or human disease agents during research, production of biologicals, or testing of pharmaceuticals, and carcasses and bedding of animals otherwise infected by zoonotic or infectious agents that may present a substantial threat to public health if improperly managed;

Page 2 6. Sharp wastes used in the diagnosis, treatment or inoculation of human beings or animals or that have, or are likely to have, come in contact with infectious agents in medical, research, or industrial laboratories, including, without limitation, hypodermic needles and syringes that contain needles, scalpel blades, and glass articles that have been broken. Such wastes are hereinafter referred to as "sharp infectious waste" or "sharps ; 7. All other waste materials generated in the diagnosis, treatment, or immunization of human beings or animals, in research pertaining thereto, or in the production or testing of biologicals, that the Public Health Council created in Section 3701.33 of the Revised Code, by rules adopted in accordance with Chapter 119 of the Revised Code, identifies as infectious wastes after determining that the wastes present a substantial threat to human health when improperly managed because they are contaminated with, or are likely to be contaminated with, infectious agents, and any other waste materials the generator designates as infectious wastes. 8. Infectious waste that is also radioactive shall be managed in accordance with applicable Ohio Department of Health regulations. B. Segregation 1. All infectious waste will be segregated from other wastes at the point of generation; for example, at the patient bedside or lab bench area. All sharps shall be placed in a "sharps" container at the point of generation. In the Hospital, only sharps containers approved by Infection Control shall be used. Sharps containers for most applications at the University Medical Center are available from Environmental Health and Radiation Safety and are serviced by a third party vendor, Daniels Sharpsmart (See HM-08-020). Sharps containers for some applications (large sharps disposal) require the individual University Medical Center department to purchase the containers via Central Supply. Any laboratory supply company may supply acceptable sharps containers for University research labs. a. Syringes that do not contain needles must be disposed of in an infectious waste container 3. All other infectious wastes and animal carcasses will be collected in bags as described in "Packaging." No animal carcasses of any kind, infectious or not, will be disposed of as solid waste in regular building trash. C. Packaging Filled non-reusable sharps containers, other infectious wastes, and all animal carcasses will be placed in impervious red plastic bags that are sufficiently strong (2 or 3 ply) to preclude ripping, tearing, or bursting under normal handling conditions. Filled red bags must be securely tied to prevent spillage before being moved from the area of generation, and then placed in a leak-proof infectious waste receptacle. These bags must be red in color and/or conspicuously labeled with the biohazard symbol. See also Policy # HM-08-020 "Disposal of Sharps. It is unacceptable for infectious waste bags and sharps containers to be stored outside of approved containers (for example, on the floor or in cardboard boxes). D. Treatment and Disposal 1. Each department or laboratory generating infectious waste shall: a. On Health Science Campus: Present properly packaged infectious wastes for collection and secondary transportation by Environmental Services. Environmental Services personnel will transport them to the locked storage room at the loading dock in Dowling Hall. b. On Main Campus: Properly package infectious wastes and either store them in a manner to prevent putrefaction (e.g. freezing) or place them in red plastic tubs provided by the infectious waste vendor retained by the Safety and Health Department for pickup, transport, and final disposal. Storage areas are located in Wolfe Hall, the Student Medical Center, and Palmer Hall.

Page 3 c. Not grind any infectious wastes nor compact any infectious wastes until after they have been appropriately treated; d. Provide and maintain documentation on the major components of their infectious waste, methods authorized by this policy utilized to treat wastes to render them non-infectious, and the department's method for distinguishing between treated and untreated infectious waste. 2. If necessary, specimen cultures and cultures of viable infectious agents may initially be treated on-site chemically. Chemically treated cultures should not be autoclaved as hazardous decomposition products may be formed. Currently, the University s autoclaves are not validated for treatment of infectious waste and such waste must be packaged for shipment to an outside treatment facility. 3. Untreated liquid or semiliquid infectious wastes consisting of blood, blood products, body fluids, and excreta may be discharged to the sanitary sewer system and need not be documented as infectious wastes. 4. Infectious wastes that have been treated to render them non-infectious may be disposed of with other solid wastes provided that sharps containers effectively contain any sharp hazards and that bags are readily identifiable as having been treated. 5. Those departments requesting authority to treat their infectious wastes must have a plan in place to demonstrate and document compliance with Rule 3745-27-32 of the OAC. That plan must be reviewed by the Environmental Health and Radiation Safety Department and must address compliance with said policy. 6. Alternate treatment methods may be used as long as they are those specifically mentioned in OAC 3745-27-32, and have been approved by the Environmental Health and Radiation Safety Department. E. For Autoclaving (only when area is approved for final treatment of infectious waste by the Safety & Health Department): (Currently, no department meets this criteria.) 1. All autoclaves must be operated at minimum temperature of 250 degrees Fahrenheit at a minimum of 15 pounds per square inch for a minimum of 60 minutes (dependent on quantity and density of the load) sufficient to render waste non-infectious. Other combinations of operational parameters of temperature, pressure, and time below the minimums stated in paragraph OAC 3745-27-32 (K)(3(e), are also exceptable, if validated, with the supervision of local authorities. Validation testing must be completed prior to the autoclave being used to treat infectious materials by the Environmental Health and Radiation Safety Department and the Ohio EPA.. 2. All departments utilizing autoclaves to treat infectious wastes shall adopt and post in the immediate area of the autoclave; standard written operating procedures to address; time, temperature, pressure, types of infectious wastes (including types of containers and container closures) to be treated, pattern and maximum quantity of loading and liquid content. 3. Each package of waste in a load shall have heat-sensitive tape or the equivalent to indicate the attainment of adequate temperature conditions. 4. After autoclaving, all sharps must be managed in a manner to eliminate the potential of those wastes to cause lacerations or puncture wounds during handling, transportation and disposal. 5. All autoclaves must be evaluated monthly under full load conditions for effectiveness against spores of Bacillus stearothermophilus or other FDA approved indicator. Such evaluation shall be conducted by placing spores of Bacillus stearothermophilus within the interior of a bag of simulated infectious waste. The bag of simulated waste shall be treated and the spore removed and incubated for a period of one week. Failure to achieve satisfactory spore test results will be immediately reported to Biomedical Engineering for appropriate action. The autoclave will not be used until effective operation is documented. 6. At each autoclave unit a log shall be maintained that provides (for infectious waste); the date the waste is treated, the start and stop time of each cycle, the operator's name, extension, room number, whether the

Page 4 waste treated is infectious or not. Each operator is obligated to complete the forms provided at the autoclave, relative to the above information. The operator on a daily basis is required to write on the log the temperature and pressure correlation during a run to determine proper autoclave performance as indicated by a posted steam chart with a ± 2 units in F or C or in PSI. Failure to achieve proper temperature and pressure correlation is cause for taking autoclave out of service and contacting Biomedical Engineering (419.383.4899) or the Environmental Health and Radiation Safety Department (419.530.3600). 7. The log, temperature graphs, spore test results and maintenance reports shall be collected and provided to the the Environmental Health and Radiation Safety Department weekly by the staff assigned this responsibility and shall be maintained by the Environmental Health and Radiation Safety Department for a minimum of three years. 8. Autoclaves are not to be used for the final treatment of animal or human pathological waste unless approved by the Ohio EPA and the Environmental Health and Radiation Safety Department. F. For chemical treatment of cultures; 1. Approved chemical treatment solutions are sodium or potassium hypochlorite at a 15% volume per volume concentration, for the treatment of surface colonies or colonies in suspensions. 2. All cultures shall be submerged for a minimum of 20 minutes to assure that waste is rendered noninfectious, or as recommended by the literature. Liquid treated waste may be sent to the sanitary sewer system as long as they do not congeal or clog waste lines. G. For infectious wastes to be disposed of through the infectious waste contractor retained by the the Environmental Health and Radiation Safety Department: 1. Wastes shall be packaged as described in Packaging by the department or laboratory generating the waste. 2. Environmental Services must be notified of infectious waste activity and arrangements made with Environmental Services as to the location of materials identified for infectious waste disposal. 3. Environmental Services will ensure materials so identified are packaged in accordance with the requirements of the infectious waste disposal firm (i.e., securely tied). 4. The the Environmental Health and Radiation Safety Department will ensure that transportation and disposal of these infectious wastes are completed in a manner consistent with OAC Rule 3745-27-31, -32, and -33 and that appropriate permits and licenses are maintained. 5. The the Environmental Health and Radiation Safety Department shall ensure that manifests documenting the treatment or destruction of infectious wastes by the infectious waste disposal vendor is obtained and retained as required by OAC. 6. HSC-containerized wastes pass through an area radiological monitor maintained by the Environmental Health and Radiation Safety Department. If the area monitor detects any radiation, an alert is sent to Environmental Health and Radiation Safety. Radition Safety personnel will then survey the containers with a GM Meter to identify the container. The container will be separated from and stored and disposed of according to Radiation Safey procedures. 7. Waste containers are routinely scanned at the infectious waste vendor s receiving facility. Any container that produces a screening alert is selected for further monitoring. Any container emitting radioactiviy in excess of 50 µrem/hr will be immediately rejected for treatment. The treatment facility will then contact the University to retrieve the affected container.

Page 5 8. The treatment facility will immediately reject any waste received at its infectious waste facilities which measures in excess of 50 urem/hour. The treatment facility will hold any waste received at its infectious waste facilities which measures less than or equal to 50 urem/hour but more than background for a maximum of 14 days. If stored waste has not decayed to background during this period, the waste will be rejected. The treatment facility will immediately notify the Ohio EPA verbally, followed by a written notification of any waste received which exhibits a radioactive level above background. Wastes which are rejected will be returned to the University of Toledo with the next regular service date. The returned container will have a copy of its manifest attached. The driver will provide Environmental Health and Radiation Safety with a Discrepancy Report which documents the levels monitored at the treatment facility. Environmental Health and Radiation Safety will immediately notify the Radiation Safety Office upon the container s arrival and provide support in actions they deem appropriate to investigate the discrepancy. A Environmental Health and Radiation Safety incident report will be compiled and distributed. H. Spills of Infectious Waste 1. All areas treating (i.e. autoclaving), packaging, storing, or otherwise handling infectious waste shall implement the procedures attached to the biohazard spill kit located within their department. These areas are responsible for contacting the Environmental Health and Radiation Safety Department to obtain a new spill kit as their current kit becomes depleted. 2. All spills of infectious waste involving greater than one cubic foot of waste must be reported to the the Environmental Health and Radiation Safety Department, within 24 hours. This report must include the exact location of the spill/release, the names of all employees involved, the date and time of the spill/release, a short detailed summary of events and the procedure used to clean the spill or release. All other spills less than one cubic foot must be reported in a timely manner to Environmental Health and Radiation Safety including the above information, for documentation on Hazardous Material Incident Report. The Environmental Health and Radiation Safety Department must maintain this document for a minimum of three years. I. All infectious material waste activity shall be compiled into a summary report; listing area removed from, quantity, location of disposal and date, and is reported to the Safety & Health Committee on a routine basis. The Environmental Health and Radiation Safety Manager shall review the above reports and analyze its contents for trends and common occurrences. Decisions will be made as to the appropriateness of further actions in relation to these tendencies. During this review period, any further follow-ups will be generated immediately and proposed to the appropriate department manager.

Page 6 J. Premises Educare Center 1932 Birchwood Ave. Glendale Medical Center 3355 Glendale Ave. Glendale Medical East 3333 Glendale Ave. Lake Erie Center 6200 Bayshore Rd. Oregon OH 43618 UT Main Campus 2801 W. Bancroft St. Toledo OH 43606 UTMC Family Physicians Fallen Timbers 2000 Elm St. Ste. 705 Maumee OH 43537 UT Health Science Campus 3000 Arlington Ave. North Engineering (Main Campus) 1700 N. Westwood Ave. Toledo OH 43607 UTMC Family Physicians 4204 Sylvania Ave. Toledo OH 43623 References: Ohio Administrative Code, Chapters 3745-27 and 3745-37. Source: Safety & Health Committee Effective Date: 6/8/92 Infection Control Review/Revision Date: 9/20/96 3/1/99 7/22/02 3/1/05 2/7/08 2/2/11 8/22/11 8/20/14 11/17/14 11/10/17